Yahoo Finance

Altamira Therapeutics’ CEO Interviewed by Proactive Investors to Discuss its Pipeline of RNA Therapeutics and Ongoing Strategic Transformation

Altamira’s patented RNA delivery technology platform is addressing strong need for reaching target cells outside the liver and for enhanced release of RNA molecules within cells First development ...
Yahoo Finance

Altamira Therapeutics Announces Successful Nanoparticle-Based Delivery of DNA Molecules

HAMILTON, BERMUDA / ACCESS Newswire / November 3, 2025 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCQB:CYTOF), a company dedicated to developing and commercializing nucleic acid ...
Benzinga.com

Why Altamira Therapeutics Stock Is Racing Higher

Under the terms of the agreement, Univercells will test a proprietary mRNA vaccine delivered with Altamira’s SemaPhore nanoparticle platform. If the experiments are successful, the companies intend to ...
techtimes

Building Beyond Code: How Altamira’s CEO Shapes Success Through Purpose, Precision, and Partnership

Altamira was founded with a clear mission: to build meaningful solutions that solve real problems without ambitions to become the biggest. CEO Kristian Samler points out that Altamira's journey is not ...
Morningstar

Altamira Therapeutics Provides Business Update and Reports Full Year 2025 Financial Results

Advancing plans for spin-off of nucleic acid delivery business and continuing strategic repositioning HAMILTON, BERMUDA / ACCESS Newswire / March 31, 2026 / Altamira Therapeutics Ltd. ("Altamira" or ...
Nasdaq

Altamira Therapeutics Announces Publication Highlighting Potential of RNA Nanoparticles for Disease-Modifying Treatment of Osteoarthritis

HAMILTON, BM / ACCESS Newswire / April 13, 2026 / Altamira Therapeutics Ltd. ("Altamira" or the "Company") (OTCID:CYTOF), a company dedicated to developing and commercializing RNA delivery technology ...